401 filings
Page 11 of 21
POS AM
fmudlm8q
30 Mar 05
Prospectus update (post-effective amendment)
12:00am
8-K
mzup38cn417ju3tr j03
29 Mar 05
Entry into a Material Definitive Agreement
12:00am
8-K
c2arg
22 Mar 05
Oscient Pharmaceuticals Names Gary Patou, M.D. to Board
12:00am
8-K
0gtu li1iel
8 Feb 05
Entry into a Material Definitive Agreement
12:00am
8-K
j91aw3m2k73ugnw87
10 Jan 05
Oscient Pharmaceuticals’ Board of Directors Names 25-Year Lilly Veteran John E. Voris to Board
12:00am
8-K
m362cuj o8jdmhaj6rn
10 Jan 05
Other Events
12:00am
8-K/A
x10 6dl91
7 Jan 05
Oscient Pharmaceuticals Hires Nick Colangelo as Senior Vice President of Corporate Development and Operations
12:00am
8-K
u9j5uwr2oeptz
6 Jan 05
Oscient Pharmaceuticals Hires Nick Colangelo as Senior Vice President of Corporate Development and Operations
12:00am
POS AM
c2glx v5078lmpw
20 Dec 04
Prospectus update (post-effective amendment)
12:00am
424B3
58ye8m0j3yw60
7 Dec 04
Prospectus supplement
12:00am
CORRESP
76amb
3 Dec 04
Correspondence with SEC
12:00am
8-K
o9n9t62negohe6ww882
10 Nov 04
Launch of FACTIVE Tablets Highlights Quarter
12:00am
UPLOAD
80r7k
16 Aug 04
Letter from SEC
12:00am
8-K
col yjs5y4
12 Aug 04
Other events
12:00am
8-K
oz8e09bsdw6x b4e8y0
10 Aug 04
Oscient Pharmaceuticals Releases Preliminary Results from Phase II
12:00am